Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

October 1, 2025

Conditions
Breast Cancer MetastaticBreast Carcinoma
Interventions
DIAGNOSTIC_TEST

Malign Lymph Node Washout

During routine axillary lymph node sampling, which is performed as part of standard staging using imaging methods, a washout sample (which is not not routinely applied ) will be obtained by injecting 1 cc of 0.9% saline into axillary lymph nodes suspected to be metastatic. The aspirated washout sample will be placed in a biochemistry gel tube labeled as Sample 1.

DIAGNOSTIC_TEST

Benign Lymph Node Washout

Description: During the biopsy performed to histopathologically confirm the benign nature of a radiologically presumed benign axillary lymph node, a washout sampling will also be conducted by injecting 1 cc of 0.9% saline into benign lymph node. The aspirated washout sample will be placed in a biochemistry gel tube labeled as Sample 2.

Trial Locations (1)

34098

RECRUITING

Istanbul Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Istanbul Training and Research Hospital

OTHER_GOV